User:Mr. Ibrahem/Elacestrant

Elacestrant, sold under the brand name Orserdu, is a medication used to treat breast cancer. Specifically it is used for ER-positive, HER2-negative, ESR1-mutated advanced disease that has failed other treatment. It is used in women after menopause or in men. It is taken by mouth.

Common side effects include musculoskeletal pain, nausea, increased cholesterol, elevated liver enzymes, increased triglycerides, tiredness, decreased hemoglobin, decreased sodium, kidney problems, diarrhea, headache, constipation, abdominal pain, hot flashes, and upset stomach. Use in pregnancy may harm the baby. It may interact with medications that affect CYP3A4. It works by blocking the action of estrogens.

Elacestrant was approved for medical use in the United States in 2023. In the United States it costs about 22,500 USD per month.